As a result, a total of 73 patients including 25 patients with recurrence and 48 patients with nonrecurrence were used for further analyses (Fig. 1), after removing seven samples with ambiguity in the recurrence state; two different types of total RNA-seq data were generated from each of the 146 specimens, i.e., 73 tumor-derived transcriptomes and 73 site paired NAT-derived transcriptomes. Here, BRD2 is linked to neoplasm.